61
Views
3
CrossRef citations to date
0
Altmetric
Review

Early interventions to prevent retinal vasculopathy in diabetes: a review

&
Pages 71-80 | Published online: 31 Aug 2015

References

  • International Diabetes Federation. Key Findings Facts and Figures; 2014. Available from: http://www.idf.org/worlddiabetesday/toolkit/gp/facts-figures.
  • Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26(3):917–932.
  • Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564.
  • NLLIC Amputee Coalition. Diabetes and Lower Extremeities Fact Sheet; 2008. Available from: http://www.amputee-coalition.org/fact_sheets/amp_stats_cause.pdf. Accessed December 15. 2014.
  • National Insititue of Diabetes and Digestive and Kidney Disease Clearing House. Kidney Disease of Diabetes; 2014. Available from: http://www.niddk.nih.gov/health-information/health-topics/kidney-disease/kidney-disease-of-diabetes/Pages/facts.aspx.
  • National Eye Institute. Diabetes Fact Sheet; 2012. Available from: https://nei.nih.gov/health/diabetic/retinopathy.
  • World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus; 2011. Available from: http://www.who.int/diabetes/publications/report-hba1c_2011.pdf.
  • American Diabetes Association. Diagnosis of diabetes. Available from www.diabetes.org; 2014. Accessed December 15, 2014.
  • Suh DC, Choi IS, Plauschinat C, et al. Impact of comorbid conditions and race/ethnicity on glycemic control among the US population with type 2 diabetes, 1988–1994 to 1999–2004. J Diabetes Compl. 2010; 24(6):382–391.
  • Cai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye (Lond). 2002;16(3):242–260.
  • White NH, Cleary PA, Dahms W, et al. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr. 2001;139(6):804–812.
  • The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med. 1993;329:977–986.
  • Alder VA, Su EN, Yu DY, et al. Diabetic retinopathy: early functional changes. Clin Exp Pharmacol Physiol. 1997;24(9–10):785–788.
  • Ways D, Sheetz MJ. The role of protein kinase C in the development of the complications of diabetes. Vitam Horm. 2001;60:149–159.
  • Naruse K, Nakamura J, Hamada Y, et al. Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes. Exp Eye Res. 2000;71(3):309–315.
  • Gurler B, Vural H, Yilmaz N, et al. The role of oxidative stress in diabetic retinopathy. Eye (Lond). 2000;14(Pt 5):730–735.
  • Sone H, Deo BK, Kumagai AK. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Invest Ophthalmol Vis Sci. 2000;41(7):1876–1884.
  • Chu J, Ali, Y. Diabetic retinopathy: a reivew. Drug Dev Res. 2008;69:1–14.
  • Tarr JM, Kaul K, Chopra M, et al. Pathophysiology of diabetic retinopathy. ISRN Ophthalmol. 2013;2013:343560.
  • Colwell JA, Halushka PV, Sarji K, et al. Altered platelet function in diabetes mellitus. Diabetes. 1976;25(2 Suppl):826–831.
  • Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes. 2015;6(1):92–108.
  • Zhang W, Liu H, Al-Shabrawey M, et al. Inflammation and diabetic retinal microvascular complications. J Cardiovasc Dis Res. 2014;2(2): 96–103.
  • Singh R, Ramasamy K, Abraham C, et al. Diabetic retinopathy: an update. Indian J Ophthalmol. 2008;56(3):178–188.
  • Friedlander M. Fibrosis and diseases of the eye. J Clin Invest. 2007; 117(3):576–586.
  • Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112(9):1217–1228.
  • Wu L, Fernandez-Loaiza P, Sauma J, et al. Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes. 2013;4(6): 290–294.
  • Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol. 1985;103(12):1796–1806.
  • Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):703–713.
  • Ueda H. Importance of serum cholesterol level in development of diabetic autonomic neuropathy. Diabetes Res Clin Pract. 1993;21(2–3):123.
  • The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976;81(4): 383–396.
  • Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs – an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98(5 Suppl):786–806.
  • Kim JE, Pollack JS, Miller DG, et al. ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema. Retina. 2008;28(5):735–740.
  • Beck RW, Edwards AR, Aiello LP, et al. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol. 2009; 127(3):245–251.
  • Rishi P, Rishi E, Kuniyal L, et al. Short-term results of intravitreal dexamethasone implant (OZURDEX®) in treatment of recalcitrant diabetic macular edema: a case series. Oman J Ophthalmol. 2012;5(2):79–82.
  • Messenger WB, Beardsley RM, Flaxel CJ. Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema. Drug Des Devel Ther. 2013;7:425–434.
  • Do DV, Schmidt-Erfurth U, Gonzalez VH, et al. The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema. Ophthalmology. 2011;118(9):1819–1826.
  • Wells JA, Glassman AR, Ayala AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13): 1193–1203.
  • Bandello F, Lattanzio R, Zucchiatti I, et al. Pathophysiology and treatment of diabetic retinopathy. Acta Diabetol. 2013;50(1):1–20.
  • American Diabetes Association. Eye Complications; 2013. Available from: http://www.diabetes.org/living-with-diabetes/complications/eye-complications/.
  • Shea AM, Curtis LH, Hammill BG, et al. Resource use and costs associated with diabetic macular edema in elderly persons. Arch Ophthalmol. 2008;126(12):1748–1754.
  • Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology. 1991; 98(5 Suppl):741–756.
  • Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology. 1991;98(5 Suppl):823–833.
  • Ruamviboonsuk P, Teerasuwanajak K, Tiensuwan M, et al. Interobserver agreement in the interpretation of single-field digital fundus images for diabetic retinopathy screening. Ophthalmology. 2006;113(5): 826–832.
  • Weiler D, Engelke CB, Moore ALO, et al. Arteriole tortuoisty associated with diabetic retinopathy and cholesterol. Optom Vis Sci. 2015;92(3).
  • Patra S, Gomm EM, Macipe M, et al. Interobserver agreement between primary graders and an expert grader in the Bristol and Weston diabetic retinopathy screening programme: a quality assurance audit. Diabet Med. 2009;26(8):820–823.
  • Kinyoun J, Barton F, Fisher M, et al; The ETDRS Research Group. Detection of diabetic macular edema. Ophthalmoscopy versus photography – early treatment diabetic retinopathy study report number 5. Ophthalmology. 1989;96(6):746–750; discussion 750–751.
  • Kinyoun JL, Martin DC, Fujimoto WY, et al. Ophthalmoscopy versus fundus photographs for detecting and grading diabetic retinopathy. Invest Ophthalmol Vis Sci. 1992;33(6):1888–1893.
  • Shi L, Wu H, Dong J, et al. Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis. Br J Ophthalmol. doi:10.1136/bjophthalmol-2014-305631.
  • American Academy of Ophthalmology. Preferred Practice Pattern®. Diabetic retinopathy. Available from: http://one.aao.org/CE/PracticeGuidelines; 2008. Accessed December 15, 2014.
  • Brady CJ, Villanti AC, Pearson JL, et al. Rapid grading of fundus photographs for diabetic retinopathy using crowdsourcing. J Med Internet Res. 2014;16(10):e233.
  • Sun C, Wang JJ, Mackey DA, et al. Retinal vascular caliber: systemic, environmental, and genetic associations. Surv Ophthalmol. 2009;54(1): 74–95.
  • Jeganathan VS, Sabanayagam C, Tai ES, et al. Retinal vascular caliber and diabetes in a multiethnic Asian population. Microcirculation. 2009;16(6):534–543.
  • Kifley A, Wang JJ, Cugati S, et al. Retinal vascular caliber, diabetes, and retinopathy. Am J Ophthalmol. 2007;143(6):1024–1026.
  • Tikellis G, Wang JJ, Tapp R, et al. The relationship of retinal vascular calibre to diabetes and retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetologia. 2007;50(11):2263–2271.
  • Knudtson MD, Lee KE, Hubbard LD, et al. Revised formulas for summarizing retinal vessel diameters. Curr Eye Res. 2003;27(3):143–149.
  • Suner I. Ultra-widefield fluorescein angiography in the diagnosis and management of diabetic retinopathy. Retina Today. 2010;(July/August):56–58.
  • Wessel MM, Aaker GD, Parlitsis G, et al. Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy. Retina. 2014;32(4):785–791.
  • Yoshitake S, Murakami T, Uji A, et al. Clinical relevance of quantified fundus autofluorescence in diabetic macular oedema. Eye (Lond). Epub March 13, 2015.
  • Virgili G, Menchini F, Casazza G, et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database System Rev. 2015;1:CD008081.
  • Horii T, Murakami T, Nishijima K, et al. Optical coherence tomographic characteristics of microaneurysms in diabetic retinopathy. Am J Ophthalmol. 2010;150(6):840–848.
  • Bronson-Castain KW, Bearse MA Jr, Neuville J, et al. Adolescents with Type 2 diabetes: early indications of focal retinal neuropathy, retinal thinning, and venular dilation. Retina. 2009;29(5):618–626.
  • Cabera DeBuc D, Somfal, GM. Early detection of retinal thickness changes in diabetes using optical coherence tomography. Med Sci Monit. 2010;16(3):15–21.
  • Harrison WW, Chang A, Cardenas MG, et al. Blood pressure, vessel caliber, and retinal thickness in diabetes. Optom Vis Sci. 2012;89(12): 1715–1720.
  • Sander B, Thornit DN, Colmorn L, et al. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter. Invest Ophthalmol Vis Sci. 2007;48(9):3983–3987.
  • Dhamdhere KP, Bearse MA Jr, Harrison W, et al. Associations between local retinal thickness and function in early diabetes. Invest Ophthalmol Vis Sci. 2012;53(10):6122–6128.
  • Sugimoto M, Sasoh M, Ido M, et al. Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy. Ophthalmologica. Int J Ophthalmol. 2005;219(6):379–385.
  • Miura M, Hong YJ, Yasuno Y, et al. Three-dimensional vascular imaging of proliferative diabetic retinopathy by Doppler optical coherence tomography. Am J Ophthalmol. 2015;159(3):528–538.
  • Bek T. Fine structure in diabetic retinopathy lesions as observed by adaptive optics imaging. A qualitative study. Acta Ophthalmol. 2014; 92(8):753–758.
  • Porter J, Queener H, Lin J, et al. Adaptive Optics for Vision Science: Principles, Practices, Design and Applications. Wiley, Hoboken, NJ; 2006.
  • Tam J, Dhamdhere KP, Tiruveedhula P, et al. Disruption of the retinal parafoveal capillary network in type 2 diabetes before the onset of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2011;52(12):9257–9266.
  • Tam J, Tiruveedhula P, Roorda A. Characterization of single-file flow through human retinal parafoveal capillaries using an adaptive optics scanning laser ophthalmoscope. Biomed Opt Express. 2011;2(4):781–793.
  • Tam J, Dhamdhere KP, Tiruveedhula P, et al. Subclinical capillary changes in non-proliferative diabetic retinopathy. Optom Vis Sci. 2012; 89(5):E692–E703.
  • Arichika S, Uji A, Murakami T, et al. Retinal hemorheologic characterization of early-stage diabetic retinopathy using adaptive optics scanning laser ophthalmoscopy. Invest Ophthalmol Vis Sci. 2014;55(12):8513–8522.
  • Lombardo M, Parravano M, Lombardo G, et al. Adaptive optics imaging of parafoveal cones in type 1 diabetes. Retina. 2014;34(3):546–557.
  • Chui TY, Gast TJ, Burns SA. Imaging of vascular wall fine structure in the human retina using adaptive optics scanning laser ophthalmoscopy. Invest Ophthalmol Vis Sci. 2013;54(10):7115–7124.
  • Rossi EA, Roorda A. The relationship between visual resolution and cone spacing in the human fovea. Nat Neurosci. 2010;13(2):156–157.
  • Della Sala S, Bertoni G, Somazzi L, Stubbe F, Wilkins AJ. Impaired contrast sensitivity in diabetic patients with and without retinopathy: a new technique for rapid assessment. Br J Ophthalmol. 1985;69(2): 136–142.
  • Dhamdhere KP, Schneck ME, Bearse MA Jr, et al. Assessment of macular function using the SKILL Card in adults with type 2 diabetes mellitus. Invest Ophthalmol Vis Sci. 2014;55(6):3368–3374.
  • Wolff BE, Bearse MA Jr, Schneck ME, et al. Color vision and neuroretinal function in diabetes. Doc Ophthalmol. 2015;130(2):131–139.
  • Sutter EE, Tran D. The field topography of ERG components in man – I. The photopic luminance response. Vision Res. 1992;32(3):433–446.
  • Harrison WW, Bearse MA Jr, Ng JS, et al. Reproducibility of the mfERG between instruments. Doc Ophthalmol. 2009;119(1):67–78.
  • Hood DC, Frishman LJ, Saszik S, et al. Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci. 2002;43(5):1673–1685.
  • Bearse MA Jr, Ozawa GY. Multifocal electroretinography in diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2014;14(9):526.
  • Bearse MA Jr, Adams AJ, Han Y, et al. A multifocal electroretinogram model predicting the development of diabetic retinopathy. Prog Retin Eye Res. 2006;25(5):425–448.
  • Ng JS, Bearse MA Jr, Schneck ME, et al. Local diabetic retinopathy prediction by multifocal ERG delays over 3 years. Invest Ophthalmol Vis Sci. 2008;49(4):1622–1628.
  • Harrison WW, Bearse MA Jr, Ng JS, et al. Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. Invest Ophthalmol Vis Sci. 2011;52(2):772–777.
  • Harrison WW, Bearse MA Jr, Schneck ME, et al. Prediction, by retinal location, of the onset of diabetic edema in patients with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2011;52(9): 6825–6831.
  • Tan W, Wright T, Dupuis A, et al. Localizing functional damage in the neural retina of adolescents and young adults with type 1 diabetes. Invest Ophthalmol Vis Sci. 2014;55(4):2432–2441.
  • Laron M, Bearse MA Jr, Bronson-Castain K, et al. Association between local neuroretinal function and control of adolescent type 1 diabetes. Invest Ophthalmol Vis Sci. 2012;53(11):7071–7076.
  • Adhikari P, Marasini S, Sah RP, et al. Multifocal electroretinogram responses in Nepalese diabetic patients without retinopathy. Doc Ophthalmol. 2014;129(1):39–46.
  • Joslin Center for Diabetes. Stay healthy with diabetes. Available from: http://www.joslin.org/info/Spotlight_on_New_Diabetes_Treatments.html; 2015. Accessed December 15, 2014.
  • Diabetes UK. Behind the Headlines. Available from: http://www.diabetes.org.uk/Research/Research-round-up; 2015. Accessed December 15, 2014.